ADA 2019 – American Diabetes Association’s 79th Annual Conference
From Friday, June 7 to Tuesday, June 11th, the biggest diabetes conference of the year took place in San Francisco, California—the American Diabetes Association’s 79th Annual Scientific Sessions (#ADA2019). This annual meeting brings together researchers, healthcare providers, diabetes technology companies and many more from around the globe.
During these five days, there were over 2,000 original research presentations and more than 180 sessions covering the latest advancements in research, treatment and care for people living with diabetes. That’s a lot of news to take in! Beyond Type 2 did the hard work for you: we reported live from ADA 2019 and aggregated the most important industry and technological updates here. Check out our comprehensive review of the weekend + our minute by minute breaking news coverage.
ADA 2019 In Review
The biggest diabetes conference of the year — American Diabetes Association’s 79th Annual Scientific Sessions is over, and Beyond Type 2’s editorial staff was reporting live from the conferenc...MORE
Breaking News from ADA 2019
Findings from the EMPA-REG OUTCOME® trial found that Jardiance® (empagliflozin) reduces cardiovascular and renal risk in adults with Type 2 diabetes and known cardiovascular disease • The results ...MORE
